Crenshaw Nursing Home: Psychotropic Drug Consent Failures - CA
The drug was lorazepam, a benzodiazepine. It sedates. It can cause confusion, respiratory depression, and physical dependence. For elderly nursing home residents, those risks are not minor.
At Crenshaw Nursing Home on South Longwood Avenue, inspectors found that neither Resident 16 nor Resident 41 had signed informed consent forms before the drug was administered. No documentation existed showing a physician had discussed side effects with either resident or their responsible parties. The signature line in each medical record was blank.
A physician had ordered lorazepam for Resident 41 on February 25, 2025, directing staff to give 0.25 milliliters by mouth every four hours as needed for anxiety showing up as restlessness and shortness of breath. Whether Resident 41 or anyone acting on their behalf was told this was coming, told what it was, or told what it might do to them, there is no record to show.
The facility's own Minimum Data Set Nurse said so plainly. During an interview with inspectors on March 19, she reviewed both residents' clinical records and confirmed there was nothing in either file to indicate a physician had obtained informed consent or gone over side effects with the residents or their families. She said the informed consent form should carry the physician's signature and be filed in the medical record. She said the medication should not have been given without it.
Then she said something more direct: failing to get informed consent before administering a psychotropic medication was a violation of resident rights.
That came from inside the building.
Crenshaw's own written policies said the same thing. A procedure the facility adopted in July 2022 stated that residents and their representatives have the right to decline treatment with psychotropic medications, and that staff and the physician are supposed to review the risks of not taking the medication and discuss appropriate alternatives. A separate policy from February 2021 said residents are to be informed of their health status, diagnosis, treatment recommendations, and prognosis in advance of treatment and on an ongoing basis, with their appointed representatives receiving the same information.
None of that happened here. Not for Resident 16. Not for Resident 41.
The gap between what a facility writes into its own policies and what it actually does for the people living there is one of the more reliable measures of how seriously it takes those policies. At Crenshaw, the gap was complete. The policy existed. The medication was given. The conversation never happened.
Informed consent for psychotropic drugs in nursing homes is not a formality. It is the mechanism by which a resident, or the family member or legal representative standing in for them, gets to say no. Gets to ask what this drug will do to me, and whether there is something else. Gets to weigh sedation against anxiety, dependency against restlessness. Without that conversation, the resident has no say. The drug arrives, and that is the end of it.
For Resident 41, the order came through by telephone on a Tuesday in late February. Within whatever window the "as needed" language allowed, the medication could be given. The record contains no evidence that Resident 41 or anyone speaking for them was consulted before that window opened.
Inspectors rated the harm level as minimal or potential for actual harm. The violation affected some residents.
Two people in that building received a psychotropic drug, and nobody asked them first.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Crenshaw Nursing Home from 2025-03-21 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Corrections: We strive for accuracy in everything we publish. If you believe any fact in this article is incorrect, please contact us with details, and we will review and correct it promptly.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: November 22, 2026 · Our methodology
CRENSHAW NURSING HOME in LOS ANGELES, CA was cited for violations during a health inspection on March 21, 2025.
The drug was lorazepam, a benzodiazepine.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.
